Home › Funds › Sands Capital Alternatives, LLC › ABOS

Sands Capital Alternatives, LLC position in ABOS

ACUMEN PHARMACEUTICALS INC · Health Care

Sands Capital Alternatives, LLC reported holding 3,720,105 shares of ABOS (ACUMEN PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 1.22% of its reported portfolio and ranking #15 among its reported holdings. Sands Capital Alternatives, LLC has disclosed ABOS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.72M sh
Reported value held$8.26M
Portfolio Weight1.22%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sands Capital Alternatives, LLC's ABOS position evolved

Sands Capital Alternatives, LLC first disclosed a stake in ABOS in Q3 2023 at 3,417,075 shares (US$14.2M). Across 13 filings, Sands Capital Alternatives, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 3,720,105 shares valued at US$8.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.42M $14.18M New
Q4 2023 3.42M $13.12M Hold
Q1 2024 3.42M $13.84M Hold
Q2 2024 3.42M $8.27M Hold
Q3 2024 3.42M $8.47M Hold
Q4 2024 3.42M $5.88M Hold
Q1 2025 3.42M $3.76M Hold
Q2 2025 3.42M $3.96M Hold
Q3 2025 3.42M $5.84M Hold
Q4 2025 3.42M $7.21M Hold
Q1 2026 3.72M $8.78M Add
Q2 2026 3.72M $9.93M Hold
Q3 2026 3.72M $8.26M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABOS and 13F data

ABOS (ACUMEN PHARMACEUTICALS INC) is a Health Care company. 27 other funds we track also report a position in ABOS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$56.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABOS

All ABOS fund holders →

FAQ

How long has Sands Capital Alternatives, LLC held ABOS?

Sands Capital Alternatives, LLC has disclosed ABOS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Sands Capital Alternatives, LLC's current position in ABOS?

As of Q3 2026, Sands Capital Alternatives, LLC holds 3.72M shares of ABOS (ACUMEN PHARMACEUTICALS INC), valued at $8.26M, representing 1.22% of its reported portfolio and ranking #15.

Has Sands Capital Alternatives, LLC been buying or selling ABOS?

In the latest 13F filing (Q3 2026), Sands Capital Alternatives, LLC held unchanged its position in ABOS.

Which other funds hold ABOS?

Other major institutional holders of ABOS include RA CAPITAL MANAGEMENT, L.P., among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.